Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S6W-42148 · Session 6

What discussions it has had with NHS England, NHS Wales and HSC Northern Ireland in relation to a joint response to evidence regarding the …

Answered Asked by Alex Cole-Hamilton LD Lodged 25 Nov 2025

The question

To ask the Scottish Government what discussions it has had with NHS England, NHS Wales and HSC Northern Ireland in relation to a joint response to evidence regarding the risks for people affected by exposure to diethylstilbestrol (DES) as a result of their mother using the drug during pregnancy.

The answer

Answered by Jenni Minto on 3 Dec 2025 · 8 days after it was lodged, on time

The Scottish Government has the utmost sympathy for the women who may have been harmed by stilbestrol. However, Scottish Ministers have had no discussions with NHS England, NHS Wales and HSC Northern Ireland on this issue as the regulation for the licensing, safety and efficacy of medicines is reserved to the UK Government and is the responsibility of the Medicines and Healthcare products Regulatory Agency (MHRA).

In the Official Report

No contribution in the Official Report cites S6W-42148 by reference.